Search filters

List of works by Barbara Burtness

A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma

scientific article published on 8 January 2015

A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311

scientific article published on 14 July 2020

A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a trial of the Eastern Cooperative Oncology Group (E1303).

scientific article

Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized c

scientific article

Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial

scientific article published on 13 June 2019

Aurora kinases in head and neck cancer

scientific article

Clinical Outcomes of Head and Neck Cancer Patients Who Undergo Resection, But Forgo Adjuvant Therapy

scientific article published on 01 September 2019

Comment on "epidermal growth factor receptor is essential for toll-like receptor 3 signaling"

scientific article published on 11 December 2012

Comparative prognostic value of epidermal growth factor quantitative protein expression compared with FISH for head and neck squamous cell carcinoma

scientific article published on 25 February 2011

Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer

scientific article published on 25 November 2020

Dysplasia at the margin? Investigating the case for subsequent therapy in 'low-risk' squamous cell carcinoma of the oral tongue

scientific article

E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group

scientific article published on 28 December 2016

Epidermal growth factor receptor, p53 mutation, and pathological response predict survival in patients with locally advanced esophageal cancer treated with preoperative chemoradiotherapy.

scientific article published in December 2003

Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression

scientific article published on September 2013

Further clinical interpretation and implications of KEYNOTE-048 findings - Authors' reply

scientific article published on 01 August 2020

Head and Neck Cancers, Version 1.2015.

scientific article published on July 2015

Head and neck cancer

article

Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology

scientific article published in October 2014

High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study ⬇️

scientific article published on October 1, 1998

Human Papillomavirus Genotypes Conferring Poor Prognosis in Head and Neck Squamous Cell Carcinoma

scientific article published on 8 September 2016

Impact of contralateral lymph nodal involvement and extranodal extension on survival of surgically managed HPV-positive oropharyngeal cancer staged with the AJCC eighth edition

scientific article published on 17 October 2019

Increased recurrences using intensity-modulated radiation therapy in the postoperative setting

scientific article published on 01 December 2010

Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancer

scientific article published on 16 March 2010

Management of Human Papillomavirus–Positive and Human Papillomavirus–Negative Head and Neck Cancer ⬇️

scientific article published on July 1, 2012

Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer ⬇️

scientific article published on June 1, 2003

Mucosal melanoma of the head and neck

scientific article published on 01 March 2012

Multi-Modality Therapy for Cancer of the Esophagus and GE Junction ⬇️

scientific article published on September 1, 2012

NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018

scientific article published on 01 May 2018

NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.

scientific article published in June 2017

NCCN Task Force Report: Management of dermatologic and other toxicities associated with EGFR inhibition in patients with cancer.

scientific article published on May 2009

National treatment patterns in patients presenting with Stage IVC head and neck cancer: analysis of the National Cancer Database

scientific article published on 16 October 2015

National treatment times in oropharyngeal cancer treated with primary radiation or chemoradiation

scientific article published on 26 May 2018

Neuregulin Signaling Is a Mechanism of Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma

scientific article published on 06 August 2019

Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: the Fox Chase Cancer Center experience

scientific article

Nuclear epidermal growth factor receptor and p16 expression in head and neck squamous cell carcinoma

scientific article published on 19 October 2012

PTEN loss is associated with resistance to cetuximab in patients with head and neck squamous cell carcinoma

scientific article published on 04 March 2019

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

scientific article published on 01 November 2019

Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412

scientific article published on 03 June 2020

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

scientific article published on 30 November 2018

Phase I/II study of ADXS11-001 or MEDI4736 immunotherapies alone and in combination, in patients with recurrent/metastatic cervical or human papillomavirus (HPV)-positive head and neck cancer

scientific article published on 4 November 2015

Phase II trial of weekly docetaxel/irinotecan combination in advanced pancreatic cancer

scientific article published on 01 July 2007

Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

scientific article published on 16 October 2019

Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study

scientific article

Phase III randomized, placebo-controlled trial of docetaxel with or without gefitinib in recurrent or metastatic head and neck cancer: an eastern cooperative oncology group trial

scientific article published on 4 March 2013

Phospho-T356RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck

scientific article

Predicting survival in head and neck squamous cell carcinoma from TP53 mutation.

scientific article

Predictive classifier for intensive treatment of head and neck cancer

scientific article published on 05 October 2020

Pregnancy-associated breast cancer

scientific article published on 01 March 2005

Primary Treatment Selection for Clinically Node-Negative Merkel Cell Carcinoma of the Head and Neck

scientific article published on 20 October 2020

Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancer

scientific article

Purpose of Induction Chemotherapy in E1308 and Importance of Patient-Reported Outcomes in Deintensification Trials

scientific article published on 21 April 2017

Quantification of excision repair cross-complementing group 1 and survival in p16-negative squamous cell head and neck cancers

scientific article

Radiation therapy treatment facility and overall survival in the adjuvant setting for locally advanced head and neck squamous cell carcinoma

scientific article published on 12 February 2019

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

scientific article published on 15 November 2018

Reply to A. Garden et al

scientific article published on 21 April 2017

Survivin expression and impact on head and neck cancer outcomes

scientific article published on 19 November 2020

Targeted therapies: Molecular selection for 'smart' study design in lung cancer

scientific article published on November 1, 2010

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

scientific article published on 15 July 2019

The tumor genome in human immunodeficiency virus-related head and neck cancer: Exploitable targets?

scientific article published on 20 October 2017

Treatment Delays in Primarily Resected Oropharyngeal Squamous Cell Carcinoma: National Benchmarks and Survival Associations

scientific article published on 31 July 2018

Treatment guidelines and patterns of care in oral cavity squamous cell carcinoma: Primary surgical resection vs. nonsurgical treatment

scientific article

Unilateral neck therapy in the human papillomavirus ERA: accepted regional spread patterns

scientific article

Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancer

scientific article published on 08 March 2018

Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of head-and neck-cancer

scientific article published on 10 April 2010

p16 status, pathologic and clinical characteristics, biomolecular signature, and long-term outcomes in head and neck squamous cell carcinomas of unknown primary

scientific article published on 13 January 2014

Paulina is supported by:

About Paulina

Help